Panax notoginseng is a famous perennial herb widely used as material for medicine and health-care food. Due to its various therapeutic effects, research work on P. notoginseng has rapidly increased in recent years, urging a comprehensive review of research progress on this important medicinal plant. Here, we summarize the latest studies on the representative bioactive constituents of P. notoginseng and their multiple pharmacological effects, like cardiovascular protection, anti-tumor, and immunomodulatory activities. More importantly, we emphasize the biosynthesis and regulation of ginsenosides, which are the main bioactive ingredients of P. notoginseng. Key enzymes and transcription factors (TFs) involved in the biosynthesis of ginsenosides are reviewed, including diverse CYP450s, UGTs, bHLH, and ERF TFs. We also construct a transcriptional regulatory network based on multi-omics data and predicted candidate TFs mediating the biosynthesis of ginsenosides. Finally, the current three major biotechnological approaches for ginsenoside production are highlighted. This review covers advances in the past decades, providing insights into quality evaluation and perspectives for the rational utilization and development of P. notoginseng resources. Modern omics technologies facilitate the exploration of the molecular mechanisms of ginsenoside biosynthesis, which is crucial to the breeding of novel P. notoginseng varieties. The identification of functional enzymes for biosynthesizing ginsenosides will lead to the formulation of potential strategies for the efficient and large-scale production of specific ginsenosides.
8 March 2025 in International Journal of Biological Macromolecules
Panax japonicus C. A. Meyer is renowned for its significant therapeutic effects and is commonly used worldwide. Its active ingredients, triterpenoid saponins, show variation in content among different tissues. The tissue-specific distribution of saponins is potentially related to the expression of vital genes in the biosynthesis pathway. In this study, the contents of five saponins (ginsenoside Ro, chikusetsusaponin IV, chikusetsusaponin IVa, ginsenoside Rg1, and ginsenoside Rb1) in three different tissues were determined by HPLC. Transcriptome sequencing analysis identified differentially expressed genes (DEGs) involved in triterpenoid saponin biosynthesis, highlighting significant correlations between saponin contents and the expression levels of 10 cytochrome p450 monooxygenase (CYP) and 3 UDP-glycosyltransferase (UGT) genes. Cloning, sequencing, and prokaryotic expression of UGT genes confirmed the molecular weights of UGT proteins. Gene sequence alignment and phylogenetic analysis provided preliminary insights into UGT gene functions. Meanwhile, the function of one UGT gene was characterized in the yeast. These findings advance our understanding of the triterpenoid saponin biosynthesis in P. japonicus and support future research in traditional Chinese medicine (TCM) and synthetic biology.
Anthracnose is an emerging threat to Epimedium sagittatum, a cornerstone species in traditional Chinese medicine; however, its etiology in biodiversity hotspots remains unresolved. In this study, we comprehensively identified the anthracnose pathogens affecting E. sagittatum in China's Shennongjia Forest District. Through a combination of multi-locus phylogenetic analyses (based on ITS2, GAPDH, TUB2, and ACT sequences) and pathogenicity assays, we identified Colletotrichum fructicola as the primary causal agent. Beyond pathogen identification, we found that infection triggers a sharp decline in key flavonoids (epimedin A, B, and C; icariin; and icaritin). Concurrent rhizosphere microbiome profiling revealed a shift toward dysbiosis, characterized by the depletion of beneficial taxa (e.g., Annulohypoxylon, Rhizophagus, Bradyrhizobium, and Pseudomonas) and an enrichment of opportunistic ones (e.g., Rhizoclosmatium, Fusarium, and Coccidioides). Strikingly, in detached leaf assays, the plant-derived phenolic compound carvacrol inhibited the growth of C. fructicola by 86.7%. Together, our findings not only identify a pathogen of concern but also delineate a disease progression pathway primarily driven by metabolic reprogramming of the host (flavonoid depletion) and concomitant rhizosphere dysbiosis. We also propose carvacrol as a potent biocontrol agent. This work addresses critical knowledge gaps in medicinal plant pathology and proposes an eco-sustainable strategy for managing anthracnose.